← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$23K

Shares

798

Price

$29

Filed

Mar 3

Insider

Name

Washburn Theodore James Jr.

Title

Principal Accounting Officer

CIK

0001874199

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,140

Footnotes

Includes 75 shares purchased through the Company's employee stock purchase plan. | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025. | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. | The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments. | The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. | The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. | The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Filing Info

Accession No.

0001439222-26-000034

Form Type

4

Issuer CIK

0001439222

Washburn Theodore James Jr.'s History

Date Ticker Type Value
2026-03-03 AGIO $152K
2026-03-02 AGIO M $0
2026-03-02 AGIO $20K
2026-03-02 AGIO M $0
2026-03-02 AGIO $21K
2026-03-02 AGIO M $0
2026-03-02 AGIO $23K
2026-03-02 AGIO M $0
2026-03-02 AGIO M $0
2026-03-02 AGIO M $0

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$1.2M 2026-04-02
Jones Cecilia
Chief Financial Officer
$172K 2026-04-02
Washburn Theodore James Jr.
Principal Accounting Officer
$194K 2026-03-03
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$148K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Milanova Tsveta / Jones Cecilia / Gheuens Sarah / Burns James William
Chief Commercial Officer
$83K 2026-03-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$185K 2026-04-02